Q3 2024 Holdings
Filed 2024-10-24 | 37 holdings | $2.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Vanguard Index FDS(VTI) | TOTAL STK MKT | 922908769 | $294.1M | 1,038,550 | 14.6% |
| Tempus AI Inc(TEM) | CL A | 88023B103 | $230.6M | 4,074,419 | 11.5% |
| Brookfield Corp(BN) | CL A LTD VT SH | 11271J107 | $185.6M | 3,491,230 | 9.2% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $148.1M | 5,549,900 | 7.4% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $111.6M | 2,411,362 | 5.5% |
| Asml Holding N V(ASML) | N Y REGISTRY SHS | N07059210 | $111.1M | 133,336 | 5.5% |
| Salesforce Inc(CRM) | COM | 79466L302 | $100.9M | 368,560 | 5.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $85.7M | 750,000 | 4.3% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $58.5M | 1,500,000 | 2.9% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $54.3M | 2,385,000 | 2.7% |
| Alibaba Group Hldg LTD(BABA) | SPONSORED ADS | 01609W102 | $53.1M | 500,827 | 2.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $52.9M | 724,666 | 2.6% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $51.1M | 1,000,000 | 2.5% |
| Cable One Inc(CABO) | COM | 12685J105 | $41.4M | 118,403 | 2.1% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $35.4M | 1,505,315 | 1.8% |
| Merus N V | COM | N5749R100 | $35.0M | 700,000 | 1.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $34.4M | 490,000 | 1.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $32.8M | 963,663 | 1.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $32.6M | 118,383 | 1.6% |
| Pharvaris N V(PHVS) | COM | N69605108 | $31.9M | 1,725,000 | 1.6% |
| Lanzatech Global Inc | COM | 51655R101 | $30.2M | 15,814,845 | 1.5% |
| Brookfield Asset Managmt LTD(BAM) | CL A LMT VTG SHS | 113004105 | $29.7M | 627,207 | 1.5% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $28.5M | 1,544,000 | 1.4% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $26.7M | 2,500,000 | 1.3% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $20.3M | 1,100,000 | 1.0% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $19.5M | 1,150,000 | 1.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $16.2M | 1,500,000 | 0.8% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $16.2M | 175,000 | 0.8% |
| Verve Therapeutics Inc | COM | 92539P101 | $11.6M | 2,400,000 | 0.6% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $10.1M | 1,122,581 | 0.5% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $9.0M | 1,850,000 | 0.4% |
| Metagenomi Inc(MGX) | COM | 59102M104 | $3.9M | 1,800,000 | 0.2% |
| IO Biotech Inc(IOBT) | COM | 449778109 | $3.5M | 3,354,449 | 0.2% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $2.9M | 1,126,915 | 0.1% |
| Marqeta Inc(MQ) | CLASS A COM | 57142B104 | $2.2M | 441,558 | 0.1% |
| Galecto Inc(GLTO) | COM NEW | 36322Q206 | $1.2M | 99,913 | 0.1% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $628.3K | 468,902 | 0.0% |